Impact of Plasma p‐tau181 on Cognition, Motor Phenotypes, and Disease Course in ALS
Open Access
- 4 May 2026
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 13 (8) , 1711-1718
Abstract
Phosphorylated tau181 (p‐tau181), an Alzheimer's disease biomarker, was recently evaluated in amyotrophic lateral sclerosis (ALS). We investigated plasma p‐tau181 in 202 ALS/ALS‐FTD patients and 94 healthy controls, assessing cognitive performance, motor function, and longitudinal dynamics. Plasma p‐tau181 and NfL were significantly elevated in ALS, with p‐tau181 increasing over 1 year while NfL remained stable. Neither marker correlated with cognitive performance, and only NfL was associated with disease severity and progression. Plasma p‐tau181 was higher in patients with predominant lower motor neuron involvement. The results indicate that p‐tau181 reflects peripheral processes in ALS, providing a complementary, mechanistically distinct biomarker from NfL.Keywords
This publication has 21 references indexed in Scilit:
- Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocksNature Medicine, 2026
- Phosphorylated tau 181 and 217 are elevated in serum and muscle of patients with amyotrophic lateral sclerosisNature Communications, 2025
- ALS plasma biomarkers reveal neurofilament and pTau correlate with disease onset and progressionAnnals of Clinical and Translational Neurology, 2025
- Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease PathologyJAMA Neurology, 2024
- Biomarker Qualification for Neurofilament Light Chain in Amyotrophic Lateral Sclerosis: Theory and PracticeAnnals of Neurology, 2023
- Evolution of Clinical Outcome Measures and Biomarkers in Sporadic Adult‐Onset Degenerative AtaxiaMovement Disorders, 2023
- Elevated Plasma Phosphorylated Tau 181 in Amyotrophic Lateral SclerosisAnnals of Neurology, 2022
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- Alzheimer disease pathology in amyotrophic lateral sclerosisActa Neuropathologica, 2004
- The ALSFRS-R: a revised ALS functional rating scale that incorporates assessments of respiratory functionJournal of the Neurological Sciences, 1999